BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8771511)

  • 1. Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients.
    de Lorgeril M; Boissonnat P; Salen P; Monjaud I; Dureau G
    J Heart Lung Transplant; 1996 May; 15(5):539-40. PubMed ID: 8771511
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1985 Aug; 27(695):74-6. PubMed ID: 3860714
    [No Abstract]   [Full Text] [Related]  

  • 3. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1991 Jan; 33(835):1-4. PubMed ID: 1984601
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM; Katyal A
    Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the addition of fenofibrate to the simvastatin-cholestyramine combination].
    Schlienger JL
    Presse Med; 1991 Mar; 20(12):565. PubMed ID: 1827899
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
    Islami Y; Ribeiro LG
    Arq Bras Cardiol; 1988 Jul; 51(1):43-8. PubMed ID: 3073735
    [No Abstract]   [Full Text] [Related]  

  • 7. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering cholesterol in patients with coronary heart disease: are we ready yet?
    Barrett-Connor E
    Circulation; 1997 Dec; 96(12):4124-5. PubMed ID: 9416875
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypercholesterolemia treatment in a renal transplant patient.
    Devuyst O; Goffin E; Pirson Y; van Ypersele de Strihou C
    Clin Nephrol; 1994 May; 41(5):319. PubMed ID: 8050214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Zocor lobby?].
    Kruse P
    Ugeskr Laeger; 1996 Apr; 158(18):2557-8. PubMed ID: 8686012
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia.
    Walker JF; Shapiro DR
    Am J Cardiol; 1990 Mar; 65(12):19F-22F. PubMed ID: 2180267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1980 Aug; 22(16):65-6. PubMed ID: 7402175
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.
    Schulman KA; Kinosian B; Jacobson TA; Glick H; Willian MK; Koffer H; Eisenberg JM
    JAMA; 1990 Dec; 264(23):3025-33. PubMed ID: 2123013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic possibilities of a newly registered lipid suppressor].
    Mölgaard J; Olsson AG
    Lakartidningen; 1988 Oct; 85(40):3271-4. PubMed ID: 3199954
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients.
    D'Amico G; Gentile MG
    Kidney Int Suppl; 1991 Apr; 31():S65-9. PubMed ID: 2046273
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and new therapy for hypercholesterolemia.
    Hunninghake DB
    J Am Osteopath Assoc; 1988 Jul; 88(7):865-9. PubMed ID: 3215796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.